中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Dietary Supplements for the Treatment of Angelman Syndrome

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
University of California, San Diego
合作者
Baylor College of Medicine
Rady Children's Hospital, San Diego
Boston Children's Hospital
Greenwood Genetic Center
Rare Diseases Clinical Research Network

关键词

抽象

Angelman syndrome (AS) is a complex genetic disorder that affects the nervous system. The purpose of this study is to determine the effectiveness of certain dietary supplements in treating the symptoms of AS.

描述

AS is a neurologic disorder that may cause developmental delay, mental retardation, severe speech impairment, seizures, small head size, and problems with movement and balance in young children. AS is caused by a missing or incomplete chromosome 15 that is inherited from the mother. Diagnosis of AS is usually made between three and seven years of age, when the characteristic behaviors and features of the disease become most evident. Prior to AS diagnosis, the symptoms may be mistaken for cerebral palsy or autism. Physical, occupational, and speech therapy, communication skills development, and behavior modification help to improve the quality of life of these children, but other treatments are needed.

In a previous study, decreased DNA methylation, which is a type of chemical change in DNA, was observed in an individual with AS; this condition may be a primary cause of AS. It is hypothesized that promoting increased DNA methylation might reduce the severity of AS symptoms. Betaine, creatine, Metafolin, and vitamin B12 are compounds normally found in the body that are involved in the DNA methylation pathway. Increasing the concentrations of these compounds in the body may enhance DNA methylation. This study will evaluate the efficacy of four dietary supplements in treating the symptoms of AS.

This study will last 12 months. Study visits will occur at study entry and Month 12. A selected group of participants, those who meet the diagnostic criteria for autism, will also be evaluated at Month 6. At study visits, participants will undergo an electroencephalogram (EEG). Medical history, physical exam, neurological exams, and developmental assessments will also be performed. Urine and blood collection, including tests to determine the blood levels of the dietary supplements, will occur at study entry and Months 6 and 12. Participants will receive two daily doses of Metafolin, betaine, and creatine, and one daily dose of vitamin B12 for the duration of the study. Parents will be asked to complete a questionnaire at each visit to report their child's behavior while taking the dietary supplements. Parents will also be contacted by phone periodically to assess changes and/or progress in their children.

日期

最后验证: 08/31/2012
首次提交: 07/02/2006
提交的预估入学人数: 07/02/2006
首次发布: 07/05/2006
上次提交的更新: 09/20/2012
最近更新发布: 09/23/2012
首次提交结果的日期: 06/15/2011
首次提交质量检查结果的日期: 09/20/2012
首次发布结果的日期: 09/23/2012
实际学习开始日期: 06/30/2006
预计主要完成日期: 01/31/2010
预计完成日期: 01/31/2010

状况或疾病

Angelman Syndrome
Nervous System Diseases

干预/治疗

Drug: 1

Drug: 1

Drug: 1

Drug: 1

-

手臂组

干预/治疗
Experimental: 1
Participants will receive two daily doses of Metafolin, betaine, and creatine, and one daily dose of vitamin B12 for 12 months.
Drug: 1
100-200 mg per kg per day by mouth with a maximum of 6 grams divided in two daily doses

资格标准

有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- Diagnosis of AS

- In stable condition with relatively good control of seizures

- Willing to comply with treatment, study visit schedule, and study assessments

- Willing to take oral or G-tube medication

- Willing to be contacted monthly during the course of the study

- Parent or guardian willing to provide informed consent

Exclusion Criteria:

- History of liver or kidney disease

- Currently being treated for a serious acute illness

- Known hypersensitivity to any of the study drugs

- Received high-dose folate drug treatment in the 12 months prior to study entry

- Other significant medical problems, including those involving the liver, kidney, or heart

- Other comorbidities, genetic disorders, or extreme prematurity; children with autism are not excluded

结果

主要结果指标

1. Average Change in Functioning in Specific Areas of Development, Including Speech and Communications Skills, Cognitive Abilities and Daily Living Skills [Baseline, 1 year]

Primary: Bayley Scales of Infant Development measures Mental Developmental Index standard scores 0 (least skilled) - 100 (most skilled) Psychomotor Developmental Index standard scores 0 (least skilled - 10 (most skilled) Vineland Adaptive Behavior Scales (VABS), Communication standard scores 0 (least skilled) - 100 (most skilled) Daily Living Skills standard scores 0 (least skilled) - 100 (most skilled) Socialization standard scores 0 (least skilled) - 100 (most skilled) Motor Skills standard scores 0 (least skilled) - 100 (most skilled) Preschool Language Scale (PLS), Auditory Comprehension 0 (least skilled) - 100 (most skilled) Expressive Communication 0 (least skilled) - 100 (most skilled)

次要成果指标

1. Change in Levels of Betaine, Creatine, Dimethylglycine, Guanidinoacetate, Homocysteine, and Methionine. [Baseline, 1 year]

2. Change in RBC Folate [Baseline, 1 year]

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge